Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BG1 gene therapy in transfusion-dependent beta-thalassemia (beta0/betaE)
TCTR20250709014Phase 2Not yet recruiting
- Sponsor
- Program Management Unit for Competitiveness
- Start
- May 2025
- Countries
- 1
01
Overview
Phase 2, single-arm trial in beta thalassemia, sponsored by Program Management Unit for Competitiveness. Planned start May 2025; status: not yet recruiting.
02
Conditions
beta thalassemia
Beyond the preview
Go deeper on TCTR20250709014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250709014.